🚀Enjoy a 7-Day Free Trial Until Jul 20, 2024!

BO

Bonesupport Holding ABSTO Bonesupport Holding Stock Report

Price

Market cap $B

Exchange

XSTO - Nasdaq STOCKHOLM AB

FAIR VALUE

Is BONEX undervalued compared to its fair value?

The fair value of BONEX stock is hidden SEK. Relative to the market price of 267.2 SEK Bonesupport Holding AB is hidden.

BONESUPPORT HOLDING AB engages in the development and commercialization of injectable bioceramic bone graft substitutes to treat bone voids. The company is headquartered in Lund, Skane. The company went IPO on 2017-06-21...[More about valuation]

Bonesupport Holding AB Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

1.67 $B

Price:

267.2 SEK

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

0.329

FINANCIALS

Bonesupport Holding AB financial for reporting period

Income Statement

0.18 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.032 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.022 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.18 B 100%
0.17 B 93%
0.022 B 12%

Balance Sheet

0.73 B
0.57 B


Financial Position Analysis

Assets

0.73 B
Current Assets
0.45 B
Total non-current assets
0.28 B

Total current liabilities
0.14 B
Total non-current liabilities
0.011 B

Cash Flow Statement

0.013 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.017 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Bonesupport Holding AB fundamental analysis for trailing twelve months (TTM)

Profitability score


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

55 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
90 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
44 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is BONEX attractive for investment based on fundamental analysis?

BONEX stock rating is hidden. Bonesupport Holding AB is a hidden by Eyestock methodology.

Get BONEX Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

41

Gross Margin:

92

CFO / Debt ratio:

hidden

Current ratio:

3.491

Debt / Equity ratio:

0.032

ROE:

55

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

BONEX.ST analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for BONEX.ST to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Bonesupport Holding AB competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Bonesupport Holding AB dividends

BONEX.ST dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About BONEX.ST stock

About the company Bonesupport Holding AB

Market cap $B

1.67

Dividend yield

Shares outstanding

65.0556 B

BONESUPPORT HOLDING AB engages in the development and commercialization of injectable bioceramic bone graft substitutes to treat bone voids. The company is headquartered in Lund, Skane. The company went IPO on 2017-06-21. The company develops and commercialize injectable bioceramic bone graft substitutes which remodel to host bone and have the capability to elute drugs directly into the bone void. The marketed synthetic bone graft substitutes are CERAMENT BVF, CERAMENT G and CERAMENT V, which are based on the CERAMENT technology platform. The products are commercially available in Europe and the United States, as well as in India, Malaysia, Oman and Singapore. The products are developed to treat patients with fractures and bone voids caused by trauma and related surgery, as well as caused by infection or diseases, such as chronic osteomyelitis, revision arthroplasty and infected diabetic foot.

BONEX.ST profile

  • Ticker

    BONEX.ST

  • Country

    Sweden

  • Exchange

    XSTO - Nasdaq STOCKHOLM AB

  • Report currency

    SEK - Swedish krone

  • IPO date

    21 June 2017

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    92

  • City

    Lund

  • Address

    Scheelevagen 19

  • Cusip

    W2R933137